E
ElevateBio
Accelerating the rate of innovation and success in cell and gene therapy with a disruptive capital-efficient model
At a glance
- Founded
- 2018
- Headquarters
- Waltham, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Latest news
Press, funding announcements and product moves mentioning ElevateBio.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
- SBSamsara BioCapital
- RGRedmile Group
- FVF2 Ventures
- ECEcoR1 Capital
- MBMPM BioImpact
Series B and later15 investors entered at this stage
Vertex Holdings- VHVertex Ventures HC
SoftBank
Emerson Collective- VHVestinwolf Financial Holdings
Fidelity Investments- MMMatrix Capital Management
- CICitadel
- SCSurveyor Capital
- WPWoodline Partners
- L(Lee Family Office (Asia)
- ITITOCHU
- EDEDBI
- INInvus
- NNNovo Nordisk
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
10 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where ElevateBio was the backer or acquirer, 2021–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across ElevateBio's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where ElevateBio deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
ElevateBio's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about ElevateBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ElevateBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.